Skip Navigation


JAC Advance Access originally published online on November 24, 2004
Journal of Antimicrobial Chemotherapy 2005 55(1):45-50; doi:10.1093/jac/dkh479
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/1/45    most recent
dkh479v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Presterl, E.
Right arrow Articles by Graninger, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Presterl, E.
Right arrow Articles by Graninger, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

JAC vol.55 no.1 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved

Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics

E. Presterl1,*, A. J. Grisold2, S. Reichmann1, A. M. Hirschl3, A. Georgopoulos1 and W. Graninger1

1 Department of Medicine I, Division of Infectious Diseases, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna; 2 Institute of Hygiene, Medical University of Graz, Universitätsplatz 4, 8010 Graz; 3 Division of Clinical Microbiology, Institute of Hygiene and Medical Microbiology, University of Vienna, Allgemeines Krankenhaus, Waehringer Guertel 18–20, 1090 Vienna, Austria

* Corresponding author. Tel: +43-1-40400-4440; Fax: +43-1-40400-4418; Email: elisabeth.presterl{at}meduniwien.ac.at

Objectives: Viridans group streptococci (VGS) are a frequent cause of bacterial endocarditis or sepsis in patients with neutropenia. Endocarditis in particular, is associated with plaque formation on the endocardium and valve leaflets whereas VGS septicaemia in neutropenic patients is caused by the influx of oral flora bacteria through mucositic lesions. This study examined the in vitro potency for biofilm formation of clinical VGS bloodstream isolates, and the effects of antibiotics on these biofilms.

Methods: During the years 1998–2000, 40 VGS bloodstream isolates from 18 patients with endocarditis and 22 patients with severe sepsis and neutropenia were collected. The MICs of penicillin, teicoplanin and moxifloxacin were determined using the microdilution broth method according to NCCLS criteria. Biofilms were grown in microtitre plates, dyed with Crystal Violet, and the mean optical density (OD) was used for quantification. Biofilms were incubated with penicillin, teicoplanin and moxifloxacin at various concentrations starting with the MICs for the respective isolates tested.

Results: Isolates from eight out of 18 patients with endocarditis and six out of 22 patients with neutropenia formed biofilms (not significant). For the 14 isolates, the MIC90s (range) of penicillin, teicoplanin and moxifloxacin were 0.5 mg/L (0.001–0.5), 0.125 mg/L (0.025–0.125) and 0.5 mg/L (0.05–0.5), respectively. Generally, biofilms persisted although incubated with the antibiotics up to concentrations of 128x MIC. However, the ODs of biofilms after incubation with an antibiotic were significantly lower than the ODs of biofilms without antibiotic (P<0.05). A significant decrease in the biofilms with increasing antibiotic concentrations was observed for teicoplanin and moxifloxacin, but not for penicillin G.

Conclusions: VGS isolated from patients with endocarditis and patients with sepsis and neutropenia form biofilms. Biofilms persist even when exposed to antibiotics at concentrations up to 128x MIC. Nevertheless, teicoplanin and moxifloxacin reduced the density of the biofilms at concentrations ≥16xMIC. Thus, testing the effects of antibiotics on biofilms may supply useful information in addition to standard in vitro testing, particularly in diseases where biofilm formation is involved in the pathogenesis.

Keywords: neutropenia , penicillin , teicoplanin , moxifloxacin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
R. O. Darouiche, M. D. Mansouri, P. V. Gawande, and S. Madhyastha
Antimicrobial and antibiofilm efficacy of triclosan and DispersinB(R) combination
J. Antimicrob. Chemother., July 1, 2009; 64(1): 88 - 93.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
X. Ge, T. Kitten, Z. Chen, S. P. Lee, C. L. Munro, and P. Xu
Identification of Streptococcus sanguinis Genes Required for Biofilm Formation and Examination of Their Role in Endocarditis Virulence
Infect. Immun., June 1, 2008; 76(6): 2551 - 2559.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. J. A. van der Plas, G. N. Jukema, S.-W. Wai, H. C. M. Dogterom-Ballering, E. L. Lagendijk, C. van Gulpen, J. T. van Dissel, G. V. Bloemberg, and P. H. Nibbering
Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa
J. Antimicrob. Chemother., January 1, 2008; 61(1): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. Diz Dios, I. Tomas Carmona, J. Limeres Posse, J. Medina Henriquez, J. Fernandez Feijoo, and M. Alvarez Fernandez
Comparative Efficacies of Amoxicillin, Clindamycin, and Moxifloxacin in Prevention of Bacteremia following Dental Extractions.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 2996 - 3002.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Burton, P. V. Gawande, N. Yakandawala, K. LoVetri, G. G. Zhanel, T. Romeo, A. D. Friesen, and S. Madhyastha
Antibiofilm Activity of GlmU Enzyme Inhibitors against Catheter-Associated Uropathogens.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1835 - 1840.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.